#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15878	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2005	782.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1407	1407	C	909	C	851	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3414	831.7	0	.	n	.	0	A20C	SNP	20	20	A	299	299	C	501	C	477	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3414	831.7	0	.	n	.	0	T695C	SNP	695	695	T	974	974	C	921	C	851	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3414	831.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1917	1917	G	974	G,A,T	907,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3414	831.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2250	2250	C	891	C	820	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3414	831.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2324	2324	A	883	A	848	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28610	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3414	831.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2876	2876	C	891	C	832	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2288	folP	855	855	100.0	folP.l15.c4.ctg.1	1529	148.4	1	SNP	p	R229S	1	.	.	685	687	AGC	982	984	AGC	225;227;228	A;G;C	208;211;209	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5794	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3446	167.2	1	SNP	p	S91F	1	.	.	271	273	TTC	620	622	TTC	217;216;216	T;T;C,T	208;205;203,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5794	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3446	167.2	1	SNP	p	D95G	1	.	.	283	285	GGC	632	634	GGC	206;205;205	G;G;C	196;195;197	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5794	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3446	167.2	1	SNP	p	G95N	0	.	.	283	285	GGC	632	634	GGC	206;205;205	G;G;C	196;195;197	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1764	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1368	128.1	1	SNP	p	G45D	0	.	.	133	135	GGC	574	576	GGC	225;226;225	G;G;C,T	214;213;212,1	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	898	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c17.ctg.1	928	95.5	0	.	n	.	0	G98A	SNP	98	98	G	443	443	A	204	A,G	189,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	898	mtrR_promoter	250	250	99.2	mtrR_promoter.l6.c17.ctg.1	928	95.5	0	.	n	.	0	A197.	DEL	197	197	A	541	541	A	225	A	211	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2828	200.4	1	SNP	p	D86N	0	.	.	256	258	GAC	557	559	GAC	232;228;230	G;A;C	217;215;216	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2828	200.4	1	SNP	p	S87R	1	.	.	259	261	CGT	560	562	CGT	230;230;234	C;G;T	217;215;217	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2828	200.4	1	SNP	p	R87W	0	.	.	259	261	CGT	560	562	CGT	230;230;234	C;G;T	217;215;217	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2828	200.4	1	SNP	p	R87I	0	.	.	259	261	CGT	560	562	CGT	230;230;234	C;G;T	217;215;217	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5722	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2828	200.4	1	SNP	p	S88P	0	.	.	262	264	TCC	563	565	TCC	235;236;235	T,C;C;C	218,1;220;221	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4746	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2626	179.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1467	1469	GGC	255;248;246	G;G;C	235;231;226	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1303	1305	GCA	232;236;234	G;C;A	217;219;218	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1306	1308	ATC	235;235;235	A,G;T;C	218,1;219;220	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1318	1320	GTG	238;237;237	G;T;G	227;224;224	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1318	1320	GTG	238;237;237	G;T;G	227;224;224	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1822	1824	ACC	206;208;211	A;C;C	187;195;198	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1876	1878	GCG	211;212;212	G;C,T;G,A	187;167,1;181,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1876	1878	GCG	211;212;212	G;C,T;G,A	187;167,1;181,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1999	2001	AGC	174;173;171	A;G;C	159;159;157	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2008	2010	GGC	166;164;160	G;G;C	153;152;147	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4346	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2556	168.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2026	2028	CCG	139;141;145	C,G;C,G;G	102,5;105,1;112	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6524	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3129	207.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1668	1670	CCG	255;256;253	C;C;G	234;240;238	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2504	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1927	129.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	569	569	C	162	C	155	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	466	468	GAA	241;241;240	G;A;A	228;232;229	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	0	.	p	.	0	K41D	NONSYN	121	123	AAA	475	477	GAC	243;243;242	G,A;A;C,A	233,1;234;231,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	0	.	p	.	0	K120N	NONSYN	358	360	AAG	712	714	AAT	235;240;241	A;A;T	222;228;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	877	879	TCA	266;266;263	T;C;A	251;246;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	0	.	p	.	0	Q214_F215del	DEL	640	640	C	994	994	C	260	C	247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1000	1002	GTC	266;267;265	G;T;C	248;248;247	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	0	.	p	.	0	A242V	NONSYN	724	726	GCC	1072	1074	GTT	273;270;266	G;T;T	252;243;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	1	SNP	p	A121D	1	.	.	361	363	GAC	715	717	GAC	241;247;247	G;A;C	222;231;231	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	3092	porB1b	1047	1047	98.19	porB1b.l15.c17.ctg.1	1515	201.0	1	SNP	p	D121N	0	.	.	361	363	GAC	715	717	GAC	241;247;247	G;A;C	222;231;231	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11198	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4879	228.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1256	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1174	106.6	1	SNP	p	V57M	1	.	.	169	171	ATG	543	545	ATG	262;263;265	A;T;G	252;252;255	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
